Search results for "ARTERIAL"

showing 10 items of 714 documents

LED-bed therapy of cardiovascular disorders: a volunteer study

2020

Studies of the physiological response of human half-body illumination by a specially designed bed comprising large number of LEDs emitting in the red and near infrared spectral range were carried out in a group of 32 volunteers comprising healthy subjects and hypertension patients. Blood pressure, heart rate and arterial blood oxygen saturation, as well as the bed surface temperature were continuously monitored during the measurement sessions with and without aluminum foil cover on the bed surface. None of the volunteers exhibited any notable changes in the heart rate and blood oxygenation during the procedures. The LightStim LED-bed session did not produce changes of arterial pressure in n…

Aluminum foilmedicine.medical_specialtybusiness.industryBlood pressureDecreased blood pressureInternal medicineHeart rateBlood oxygenationmedicineCardiologyArterial bloodbusinessVolunteerOxygen saturation (medicine)Mechanisms of Photobiomodulation Therapy XV
researchProduct

RETRACTED ARTICLE: Hemodynamics, intra-mucosal pH and regulators of circulation during perioperative epidural analgesia

2000

Objectif: Etudier les effets de l'analgesie peridurale perioperatoire sur l'hemodynamie, la perfusion splanchnique et les regulateurs de la circulation. Methode : Vingt patients subissant un pontage aortique infrarenal ont ete repartis au hasard en deux groupes : un groupe GP recevant l'analgesie peridurale avec bupivacaine (15 ml a 0,125 %) avant l'operation, suivis de 10 ml de bupivacaine a 0,125 % et de 1 mg de morphine 8 h et 16 h apres l'operation; un groupe temoin GT sans catheter epidural. Le monitorage comprenait un catheter de l'artere pulmonaire et un tonometre gastrique. Les regulateurs de circulation etaient mesures sur des echantillons de sang : avant l'analgesie peridurale (T …

Anesthesiology and Pain MedicineCarbon dioxide bloodArterial diseasebusiness.industryAnesthesiaPerioperative careMedicineGeneral MedicinebusinessAspartic EndopeptidasesAortic diseaseCanadian Journal of Anesthesia/Journal canadien d'anesthésie
researchProduct

Optimising experimental research in respiratory diseases: an ERS statement

2018

Experimental models are critical for the understanding of lung health and disease and are indispensable for drug development. However, the pathogenetic and clinical relevance of the models is often unclear. Further, the use of animals in biomedical research is controversial from an ethical perspective.The objective of this task force was to issue a statement with research recommendations about lung disease models by facilitating in-depth discussions between respiratory scientists, and to provide an overview of the literature on the available models. Focus was put on their specific benefits and limitations. This will result in more efficient use of resources and greater reduction in the numb…

Animal Experimentation0301 basic medicinePulmonary and Respiratory Medicinemedicine.medical_specialtyBiomedical ResearchStatement (logic)Advisory CommitteeseducationMEDLINEDiseaseLung injury[SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tractHIGHLAND WHITE TERRIERSACUTE LUNG INJURY03 medical and health sciencesIdiopathic pulmonary fibrosis0302 clinical medicineINBRED MOUSE STRAINSPulmonary fibrosisAnimalsHumansMedicineIntensive care medicineSocieties MedicalALLERGIC AIRWAY INFLAMMATIONbusiness.industryCOMMUNITY-ACQUIRED PNEUMONIACIGARETTE-SMOKE EXPOSURERespiration Disordersmedicine.diseaseDISTRESS-SYNDROME3. Good healthEuropeDisease Models Animal030104 developmental biologyANIMAL-MODELS030228 respiratory systemDrug developmentData qualityARTERIAL-HYPERTENSIONIDIOPATHIC PULMONARY-FIBROSISbusiness
researchProduct

Diagnose und Verlaufsbeurteilung eines intramuralen Hämatoms der Aorta ascendens mit der Magnetresonanztomographie

1998

Aortamedicine.diagnostic_testbusiness.industryArterial diseaseVascular diseaseMagnetic resonance imagingmedicine.diseaseAortic aneurysmAneurysmmedicine.arteryAscending aortamedicineIntramural hemorrhageRadiology Nuclear Medicine and imagingbusinessNuclear medicineRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
researchProduct

Identification of cardiac organ damage in arterial hypertension: insights by echocardiography for a comprehensive assessment

2020

: Arterial hypertension, a widespread disease, whose prevalence increases with age, represents a major risk factor for cardiovascular events, causing damage in several organs, including the heart. In this context, echocardiography has a clear and pivotal role, being able to assess cardiac morphology and detect haemodynamic changes induced by this disease. 2018 European Society of Cardiology/European Society of Hypertension guidelines on AH identified main echo parameters such as left ventricular mass, relative wall thickness and left atrial volume, for detecting cardiac organ damage. The present review highlights the advantage of additional echocardiographic parameters such as diastolic mea…

Aortic valvemedicine.medical_specialtyarterial hypertensionPhysiologyHeart VentriclesDiastoleHemodynamicsContext (language use)Speckle tracking echocardiographyRegurgitation (circulation)030204 cardiovascular system & hematologyarterial hypertension; cardiac organ damage; diastolic dysfunction; echocardiography; left ventricular hypertrophy03 medical and health sciences0302 clinical medicinecardiac organ damageInternal medicineInternal MedicineMedicineHumans030212 general & internal medicineRisk factorbusiness.industrymedicine.diseasePrognosisleft ventricular hypertrophyStenosismedicine.anatomical_structureEchocardiographyAortic ValveHypertensionCardiologydiastolic dysfunctionCardiology and Cardiovascular Medicinebusiness
researchProduct

Influence of the metabolic syndrome on aortic stiffness in never treated hypertensive patients

2004

Summary Background and aim Metabolic syndrome (MS) carries an increased risk for cardiovascular events and there is a growing awareness that large artery stiffening is a powerful predictor of cardiovascular morbidity and mortality. Little is known about the relationship of MS with aortic stiffness. The aim of our study was to analyze, in patients with essential hypertension, the influence of MS, defined according to the criteria proposed by the Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (NCEP-ATP III), on carotid–femoral pulse wave velocity (PWV), a measure of aortic stiffness. Methods N…

Arterial hypertensionAdultMalemedicine.medical_specialtySettore MED/09 - Medicina InternaAmbulatory blood pressureEndocrinology Diabetes and MetabolismMedicine (miscellaneous)Essential hypertensionRisk FactorsInternal medicineDiabetes mellitusmedicineAlbuminuriaHumansPulse wave velocityNational Cholesterol Education ProgramAortaMetabolic SyndromeNutrition and Dieteticsbusiness.industryAge FactorsBlood Pressure Monitoring AmbulatoryMiddle AgedCardiovascular riskmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareElasticityFemoral ArteryPulse wave velocityAortic stiffneCarotid ArteriesBlood pressureEndocrinologyDiabetes Mellitus Type 2Blood chemistryCase-Control StudiesHypertensionCardiologyRegression AnalysisFemaleMetabolic syndromeCardiology and Cardiovascular MedicinebusinessNutrition, Metabolism and Cardiovascular Diseases
researchProduct

[PP.07.19] ASSOCIATION OF MAXIMUM SPEED OF BLOOD PRESSURE RISE DURING 24-H ABPM WITH SUBCLINICAL RENAL DAMAGE IN ESSENTIAL HYPERTENSION

2017

Objective: Experimental studies documented that the mechanical injury of intravascular pressure on the vessel wall, which results in vascular remodelling and atherosclerosis, may be more closely associated to oscillatory than to steady laminar shear stress This suggests that the hypertensive patient's prognosis may depend not only on average BP level but also on the degree and rate of BP variation. Little is known about the relationships between early renal abnormalities and the rate of BP changes assessed by intermittent 24-h ambulatory BP monitoring (ABPM). Our study was aimed to analyse the relationships between subclinical renal damage (SRD), defined as the presence of microalbuminuria …

Arterial hypertensionBlood pressure variabilitymedicine.medical_specialtySettore MED/09 - Medicina InternaPhysiologybusiness.industryRenal damageAmbulatory blood pressureEssential hypertensionmedicine.diseaseRenal dysfunction.Blood pressure riseInternal medicineInternal MedicineCardiologyMedicineCardiology and Cardiovascular MedicinebusinessSubclinical infectionJournal of Hypertension
researchProduct

Prevenzione dell’ictus cerebrale nel diabete

2005

Diversi studi epidemiologici hanno chiaramente documentato che il diabete mellito costituisce un importante fattore di rischio ictus ischemico, mettendo altresì in evidenza la peggiore prognosi delle malattie cerebrovascolari nei pazienti diabetici. Tra le varietà di stroke ischemico quella lacunare sembra essere peculiare del paziente diabetico, essendo legata a una patologia delle piccole arterie penetranti dell’encefalo, nel contesto della tipica microangiopatia diabetica. L’ipertensione arteriosa costituisce il più importante fattore di rischio modificabile di ictus nel paziente diabetico ed è ampiamente dimostrato che la sua correzione farmacologica costituisce oggi la migliore possibi…

Arterial hypertensionStrokeDiabetes mellituPrevention
researchProduct

Arterial hypertension in cancer: The elephant in the room

2019

The great therapeutical success achieved by oncology is counterbalanced by growing evidences of cardiovascular (CV) toxicity due to many antineoplastic treatments. Cardiac adverse events may cause premature discontinuation of effective oncologic treatments or occur as late events undermining the oncologic success. Arterial hypertension is both the most common comorbidity in cancer patients and a frequent adverse effect of anticancer therapies. A pre-existing hypertension is known to increase the risk of other cardiac adverse events due to oncologic treatments, in particular heart failure. Moreover, as a strict association between cancer and CV diseases has emerged over the recent years, var…

Arterial hypertensionVascular Endothelial Growth Factor AAnthracyclines Anti VEGF agents Anti-hypertensive therapy Arterial hypertension Cancer Cardiotoxicitymedicine.medical_specialtyAnti VEGF agentmedicine.medical_treatmentAntineoplastic AgentsBlood PressureAnthracycline030204 cardiovascular system & hematologyAnthracyclines; Anti VEGF agents; Anti-hypertensive therapy; Arterial hypertension; Cancer; Cardiotoxicity; Antihypertensive Agents; Antineoplastic Agents; Blood Pressure; Humans; Hypertension; Neoplasms; Vascular Endothelial Growth Factor A03 medical and health sciences0302 clinical medicineNeoplasmsmedicineHumansAnthracyclines030212 general & internal medicineAnti-hypertensive therapyAdverse effectIntensive care medicineAntihypertensive AgentsCancerChemotherapyCardiotoxicitybusiness.industryAnti VEGF agentsCancermedicine.diseaseComorbidityCardiotoxicityDiscontinuationBlood pressureHeart failureHypertensionCardiology and Cardiovascular MedicinebusinessInternational Journal of Cardiology
researchProduct

Matrix Metalloproteases in Arterial Hypertension and their Trend after Antihypertensive Treatment

2017

<b><i>Background/Aims</i></b><b><i>:</i></b> Arterial hypertension is characterized by vascular remodelling, atherosclerosis and cardiovascular complications. Matrix metalloproteases (MPPs) are endopeptidases produced by all the cells present in the vascular wall and are involved in the regulation of the extracellular matrix protein turnover. MMPs contribute to blood vessel formation, remodelling, angiogenesis; whereas an altered expression or activity of MMPs or their tissue inhibitors (TIMPs) results correlated with the development and progression of cardiovascular complications. <b><i>Methods:</i></b> We examined the…

Arterial hypertensionVascular remodelling0301 basic medicinelcsh:Diseases of the circulatory (Cardiovascular) systemmedicine.medical_specialtyAngiogenesisMatrix metalloproteasesMatrix metalloproteaseHemodynamics030204 cardiovascular system & hematologyPharmacologyMatrix metalloproteinaselcsh:RC870-923Vascular remodelling in the embryoExtracellular matrix03 medical and health scienceschemistry.chemical_compound0302 clinical medicineFibrosisInternal medicinelcsh:DermatologymedicineHumansAntihypertensive AgentsAldosteronebusiness.industryTissue Inhibitor of MetalloproteinasesGeneral Medicinelcsh:RL1-803lcsh:Diseases of the genitourinary system. Urologymedicine.diseaseMatrix Metalloproteinases030104 developmental biologymedicine.anatomical_structurechemistrylcsh:RC666-701Cardiovascular DiseasesNephrologyHypertensionCardiologyArterial hypertension; Matrix metalloproteases; Vascular remodelling; Cardiology and Cardiovascular Medicine; NephrologyCardiology and Cardiovascular MedicinebusinessBlood vesselKidney and Blood Pressure Research
researchProduct